Skip to content

Author

M. Shepard

We have 4 of 62 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

EPID-23 Prognosis in non-small cell lung cancer brain metastases in the era of targeted therapy: driver-informed nomograms

Brain metastases in non-small cell lung cancer (NSCLC-BM) remain associated with poor outcomes, and many prognostic indices predate modern targeted therapy. We developed and internally validated driver-informed nomograms using routinely available clinical, molecular, and treatment variables to estimate overall su...

Z. Sarfraz, Sankalp Das, A. McCracken et al. · 0 citations
Open access Oct 2026

Urgent versus scheduled resection in high-grade glioma: patient selection and healthcare utilization in a single-center cohort

Patients with high-grade glioma reach surgery during the initial, index hospitalization (urgent), or through scheduled/outpatient pathways. There is a paucity of literature examining what patients require expedited versus elective surgery. This single-center retrospective study describes complications, utilization, and...

Danny A. Mahmoudi, T. Kite, Eric Singh et al. · 0 citations
Sep 2026

Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.

PURPOSE Post-operative stereotactic radiation (SRT) is the standard-of-care for resected brain metastases. Implantation of cesium-131 collagen tiles (tile-based radiation therapy, TBRT) initiates focal radiation immediately after resection, potentially offering therapeutic and logistical advantages. ROADS: a randomized...

J. Weinberg, B. Imber, V. Dinapoli et al. · 0 citations
Open access Aug 2026

SADA-17 SURVIVAL AND LOCAL CONTROL AFTER RESECTION AND GAMMATILE BRACHYTHERAPY FOR NEWLY DIAGNOSED BRAIN METASTASES: A PROSPECTIVE REGISTRY ANALYSIS

In this prospective registry, resection followed by GammaTile brachytherapy achieved excellent local control, and manageable toxicity in newly diagnosed BM, supporting that GammaTile brachytherapy is a promising strategy for large or symptomatic BM.

Ruchit P. Jain, Z. Sarfraz, Mukesh Roy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.